Global WholeHealth Partners Corp (OTC: GWHP), has paid off another of its outstanding convertible notes as stated in the 8K filed on 02/17/21. The note was paid from a direct equity investment by a healthcare investor. Eliminating the second convertible note represents a significant milestone for Global WholeHealth Partners Corp (OTC:GWHP); Global will seek capital from longer term investments. Global is building a stronger financial base, by eliminating debt. Since the note was not converted into shares under the original terms, we were also able to avoid substantial dilution to our shareholders.   Given our outlook for strong growth this year and the rapidly improving fundamentals of the business, Global is getting into a position where we hopefully can fund our growth from cash flow from operations or from capital equity sources. The strong growth outlook comes from Global leading the way in the fight against CoViD19, by offering 15 Minute Rapid IgG/IgM Tests for Venous Blood, & Fingertip Blood (POC), and 90 Minute rt-PCR Tests for CoViD19 with All the Tests Being FDA EUA Authorized, one of the largest lines of tests for CoViD19 SARS2, is prepared to help in the fight against CoViD19 SARS2. About Global WholeHealth Partners Corp.: Global WholeHealth   Read more…

Findit, Inc. (OTC PINK:FDIT) owner of Findit.com, a full-service social networking platform that provides online marketing campaigns and tools for members to increase brand awareness through content creation and sharing, resulting in indexing in search engines is highlighting: Hip Hop Bling, ClassWorx (OTC PINK:CHNO), and Dr. Mary Clifton. In today’s release, Findit will be highlighting three featured members that utilize Findit marketing campaigns. Each of these members on Findit has a recurring monthly marketing campaign with Findit that helps improve their overall web presence through search and social media. Findit offers a full suite of marketing services to each of these clients, from content creation to social sharing to video production and more to heighten their overall online presence, aiding them in reaching the audience that is looking for them throughout the web. Our first featured member is Hip Hop Bling. Now the perfect time to stock up on all of your favorite bling bling jewelry, iced-out pieces and accessories for yourself, friends, and family. Hip Hop Bling sells high quality, fashion hip hop jewelry, including bracelets, chains, diamonds, watches, and more. Their jewelry offers an authentic look and feel to real diamond and gold jewelry but is offered at a more competitive   Read more…

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 19, 2021, subject to satisfaction of customary closing conditions. (PRNewsfoto/AIkido Pharma Incorporated) H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company also has granted to the underwriter a 30-day option to purchase up to an additional 7,031,250 shares of common stock at the public offering price, less underwriting discounts and commission.   The gross proceeds are expected to be approximately $75 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. The offering is being conducted pursuant to the registration statement on Form S-3 (File No. 333-238172), as amended, previously filed with and subsequently declared effective by the Securities and Exchange Commission   Read more…

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,250,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 19, 2021, subject to satisfaction of customary closing conditions. (PRNewsfoto/AIkido Pharma Incorporated) H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company also has granted to the underwriter a 30-day option to purchase up to an additional 937,500 shares of common stock at the public offering price, less underwriting discounts and commission.   The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. The offering is being conducted pursuant to the registration statement on Form S-3 (File No. 333-238172), as amended, previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”) on June 18, 2020. A final prospectus relating to the offering will be filed with the SEC and will be available on   Read more…